https://www.yiliao.com/index.php?action=history&feed=atom&title=%E7%A6%8F%E6%B2%83%E8%8D%AF%E4%B8%9A
福沃药业 - 版本历史
2026-04-18T23:26:04Z
本wiki的该页面的版本历史
MediaWiki 1.35.1
https://www.yiliao.com/index.php?title=%E7%A6%8F%E6%B2%83%E8%8D%AF%E4%B8%9A&diff=314587&oldid=prev
223.160.138.164：建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面
2026-01-16T02:19:41Z
<p>建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面</p>
<p><b>新页面</b></p><div><div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff; max-width: 1200px; margin: auto;"><br />
<br />
<div style="margin-bottom: 30px; border-bottom: 1.2px solid #e2e8f0; padding-bottom: 25px;"><br />
<p style="font-size: 1.1em; margin: 10px 0; color: #334155; text-align: justify;"><br />
<strong>[[福沃药业]]</strong>（<strong>[[Forward Pharma]]</strong>）是一家处于临床阶段的创新驱动型生物医药企业，专注于研发针对癌症及自身免疫性疾病的下一代<strong>[[精准治疗]]</strong>药物。公司由跨国制药资深专家团队创立，通过其核心的<strong>[[基于结构的药物设计]]</strong>（[[SBDD]]）平台，致力于攻克尚未被满足的临床需求。[[福沃药业]]的研发管线涵盖了多个极具潜力的[[小分子]]抑制剂，其中核心品种<strong>[[FWD1509]]</strong>在针对<strong>[[EGFR]]</strong>和<strong>[[HER2]]</strong>20号外显子插入突变的[[非小细胞肺癌]]治疗中展现了突破性的临床价值。<br />
</p><br />
</div><br />
<br />
<div class="medical-infobox mw-collapsible mw-collapsed" style="width: 320px; float: right; margin: 0 0 25px 25px; border: 1.2px solid #bae6fd; border-radius: 12px; background-color: #ffffff; box-shadow: 0 8px 20px rgba(0,0,0,0.05); overflow: hidden;"><br />
<br />
<div style="padding: 15px; color: #1e40af; background: linear-gradient(135deg, #ffffff 0%, #e0f2fe 100%); text-align: center; cursor: pointer;"><br />
<div style="font-size: 1.2em; font-weight: bold; letter-spacing: 1.2px;">[[福沃药业]]</div><br />
<div style="font-size: 0.75em; opacity: 0.85; margin-top: 4px;">Forward Pharma · 创新药研发 · 点击展开</div><br />
</div><br />
<br />
<div class="mw-collapsible-content"><br />
<div style="padding: 20px; text-align: center; background-color: #f8fafc;"><br />
<div style="padding: 12px; border: 1px solid #e2e8f0; border-radius: 8px; background: #fff; display: inline-block;"><br />
<div style="width: 140px; height: 90px; background-color: #f1f5f9; display: flex; align-items: center; justify-content: center; color: #94a3b8; font-size: 0.8em; padding: 10px; text-align: center;">[[Forward Pharma]]企业标志模型</div><br />
</div><br />
<div style="font-size: 0.8em; color: #64748b; margin-top: 12px; font-weight: 600;">核心领域：[[肿瘤]]与[[免疫]]</div><br />
</div><br />
<br />
<table style="width: 100%; border-spacing: 0; border-collapse: collapse; font-size: 0.85em;"><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0; width: 45%;">总部地址</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">[[深圳]]•[[上海]]</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">企业性质</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">生物技术公司(Biotech)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">技术平台</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #e2e8f0; color: #1e40af;">[[SBDD]] / 激酶库筛选</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">核心资产</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">[[FWD1509]]•[[FWD1302]]</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">治疗领域</th><br />
<td style="padding: 8px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">肺癌、乳腺癌、免疫炎症</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 8px 12px; background-color: #f1f5f9; color: #475569;">发展阶段</th><br />
<td style="padding: 12px; color: #0f172a;">临床后期/产业化准备</td><br />
</tr><br />
</table><br />
</div><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">核心技术平台：SBDD与分子优化</h2><br />
<br />
<p style="margin: 15px 0; text-align: justify;"><br />
[[福沃药业]]的核心竞争优势源于其系统化的药物研发引擎，通过多维技术手段实现分子的精准交付：<br />
</p><br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>基于结构的分子建模：</strong> 利用[[X射线晶体学]]和计算机模拟技术，深度解析激酶靶点（如[[EGFR]]突变体）的构象变化，设计具有高选择性的候选分子。</li><br />
<li style="margin-bottom: 12px;"><strong>差异化激酶库：</strong> 建立了针对难治性突变及耐药机制的专项化合物库，旨在解决临床上如20号外显子插入等“[[不可成药]]”或“难以成药”的靶点挑战。</li><br />
<li style="margin-bottom: 12px;"><strong>高效临床转化：</strong> 通过与全球顶尖临床机构合作，快速验证化合物的安全性与初步有效性，缩短产品从实验室到[[POC]]（[[临床概念验证]]）的时间。</li><br />
</ul><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">研发管线与产品矩阵</h2><br />
<br />
<div style="overflow-x: auto; margin: 25px auto; width: 95%;"><br />
<table style="width: 100%; border-collapse: collapse; border: 1.2px solid #cbd5e1; font-size: 0.9em; text-align: left;"><br />
<tr style="background-color: #f8fafc; border-bottom: 2px solid #0f172a;"><br />
<th style="padding: 10px; border: 1px solid #cbd5e1; color: #0f172a; width: 25%;">项目代号</th><br />
<th style="padding: 10px; border: 1px solid #cbd5e1; color: #475569;">靶点/机制</th><br />
<th style="padding: 10px; border: 1px solid #cbd5e1; color: #1e40af;">临床地位/适应症</th><br />
</tr><br />
<tr><br />
<td style="padding: 8px; border: 1px solid #cbd5e1; font-weight: 600;">[[FWD1509]]</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">[[EGFR]]/[[HER2]] Exon 20ins</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">核心主打产品，正进行中/美多中心注册临床探索。</td><br />
</tr><br />
<tr><br />
<td style="padding: 8px; border: 1px solid #cbd5e1; font-weight: 600;">[[FWD1302]]</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">[[EGFR]]/[[HER2]]/[[BTK]]</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">针对血液及实体瘤的泛激酶抑制方案。</td><br />
</tr><br />
<tr><br />
<td style="padding: 8px; border: 1px solid #cbd5e1; font-weight: 600;">[[免疫炎症管线]]</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">新型选择性激酶抑制剂</td><br />
<td style="padding: 8px; border: 1px solid #cbd5e1;">探索在[[类风湿关节炎]]等自免领域的应用。</td><br />
</tr><br />
</table><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">企业发展策略：全球化与差异化</h2><br />
<p style="margin: 15px 0; text-align: justify;"><br />
[[福沃药业]]在激烈的[[Biotech]]竞争中采取了清晰的差异化突围路径：<br />
</p><br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>深耕罕见驱动突变：</strong> 避开高度饱和的经典[[EGFR]]突变市场，率先切入20号外显子插入突变等临床急需的利基领域，建立护城河。</li><br />
<li style="margin-bottom: 12px;"><strong>双轮驱动研发：</strong> 坚持“[[自主研发]]”与“[[全球授权]]”（[[License-in/out]]）并重，优化资源配置。</li><br />
<li style="margin-bottom: 12px;"><strong>全球注册申报：</strong> 公司积极开展中、美双报，旨在提升药物的国际可及性，并利用[[FDA]]等国际监管机构的[[快速通道]]加速产品上市。</li><br />
</ul><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">关键相关概念</h2><br />
<div style="background-color: #f8fafc; border: 1px solid #e2e8f0; border-radius: 8px; padding: 15px; margin: 20px 0;"><br />
<ul style="margin: 0; padding-left: 20px; color: #334155;"><br />
<li style="margin-bottom: 8px;"><strong>[[FWD1509]]：</strong> 公司最核心的在研TKI，靶向EGFR/HER2 20ins突变。</li><br />
<li style="margin-bottom: 8px;"><strong>[[SBDD]]：</strong> 基于结构的药物设计，福沃药业的技术基石。</li><br />
<li style="margin-bottom: 8px;"><strong>[[EGFR20号外显子插入]]：</strong> 肺癌领域重要的难治性标志物。</li><br />
<li style="margin-bottom: 8px;"><strong>[[精准医疗]]：</strong> 针对特定分子分型进行的个性化治疗范式。</li><br />
</ul><br />
</div><br />
<br />
<div style="font-size: 0.92em; line-height: 1.6; color: #1e293b; margin-top: 50px; border-top: 2.2px solid #0f172a; padding: 15px 25px; background-color: #f8fafc; border-radius: 0 0 10px 10px;"><br />
<span style="color: #0f172a; font-weight: bold; font-size: 1.05em; display: inline-block; margin-bottom: 15px;">学术参考文献与权威点评</span><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[1] <strong>Wu YL, et al. (2024).</strong> <em>Phase I/II preliminary efficacy and safety results of FWD1509 in EGFR exon 20 insertion mutant NSCLC.</em> <strong>[[AACR Annual Meeting Presentation]]</strong>.[Academic Review]<br><br />
<span style="color: #475569;">[权威点评]：该数据展示了FWD1509作为国产创新TKI在罕见突变肺癌治疗中的强劲势头。</span><br />
</p><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[2] <strong>Forward Pharma R&D White Paper. (2025).</strong> <em>Structural logic and selectivity optimization of novel kinase inhibitors.</em> <strong>[[Biotech Industry Insight]]</strong>.<br><br />
<span style="color: #475569;">[核心价值]：深度解析了福沃药业在分子建模及克服脱靶毒性方面的技术底蕴。</span><br />
</p><br />
</div><br />
<br />
<div style="margin: 40px 0; border: 1px solid #e2e8f0; border-radius: 8px; overflow: hidden; font-family: 'Helvetica Neue', Arial, sans-serif; font-size: 0.9em;"><br />
<div style="background-color: #eff6ff; color: #1e40af; padding: 8px 15px; font-weight: bold; text-align: center; border-bottom: 1px solid #dbeafe;"><br />
[[福沃药业]] (Forward Pharma) 企业生态 · 知识图谱<br />
</div><br />
<table style="width: 100%; border-collapse: collapse; background-color: #ffffff;"><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">关联品种</td><br />
<td style="padding: 10px 15px; color: #334155;">[[FWD1509]]•[[FWD1302]]•[[舒沃替尼]](对标)•[[埃万妥单抗]](对标)</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">战略协作</td><br />
<td style="padding: 10px 15px; color: #334155;">[[广东省药监局]]•[[NMPA]]•[[FDA]]•[[上海瑞金医院]]</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">核心靶标</td><br />
<td style="padding: 10px 15px; color: #334155;">[[EGFR]]•[[HER2]]•[[BTK]]•[[Exon 20ins]]</td><br />
</tr><br />
<tr><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">产业定位</td><br />
<td style="padding: 10px 15px; color: #334155;">[[粤港澳大湾区生物医药集群]]•[[研发主导型Biotech]]•[[中外双报模式]]</td><br />
</tr><br />
</table><br />
</div><br />
<br />
</div></div>
223.160.138.164